McDonald Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
VCM
VPM
McDonald Partners's GILD Position: Q1 2026 in Review
McDonald Partners reduced its Gilead Sciences (GILD) stake by 3.5% in Q1 2026, selling an estimated $139K and leaving 27,300 shares worth $3.8M. The position accounts for 0.9% of the portfolio, ranked #35.
McDonald Partners first reported a position in GILD in Q4 2020 and has held it in 22 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- McDonald Partners held 27,300 shares of Gilead Sciences worth $3.8M as of Q1 2026.
- McDonald Partners sold 996 Gilead Sciences shares in Q1 2026, an estimated $139K.
- Gilead Sciences made up 0.9% of McDonald Partners's portfolio in Q1 2026, its #35 holding.
- McDonald Partners first reported a position in Gilead Sciences in Q4 2020 and has held it in 22 quarters since.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on McDonald Partners's 13F filing for Q1 2026, filed 15 May 2026.